APA (7th ed.) Citation

Ruggiero A, Picone V, Martora F, Fabbrocini G, & Megna M. (2022). Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence. Dove Medical Press.

Chicago Style (17th ed.) Citation

Ruggiero A, Picone V, Martora F, Fabbrocini G, and Megna M. Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence. Dove Medical Press, 2022.

MLA (9th ed.) Citation

Ruggiero A, et al. Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence. Dove Medical Press, 2022.